Samsara BioCapital’s CARGO Therapeutics CRGX Stock Holding History

Samsara BioCapital’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,415,689	Closed	-$18.2M	–	28
2025 Q2	$18.2M	Hold	4,415,689	–	–	3.72%	6
2025 Q1	$18M	Hold	4,415,689	–	–	3.2%	8
2024 Q4	$63.7M	Hold	4,415,689	–	–	8.74%	2
2024 Q3	$81.5M	Hold	4,415,689	–	–	15.66%	1
2024 Q2	$72.5M	Buy	4,415,689 +294,000	+7%	+$5.59M	15.17%	1
2024 Q1	$92M	Hold	4,121,689	–	–	14.23%	2
2023 Q4	$95.4M	Buy	+4,121,689	New	+$69.9M	14.84%	3

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Samsara BioCapital's CRGX Position: Q3 2025 in Review

Samsara BioCapital sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 4,415,689 shares — an estimated $18.2M sold.

Samsara BioCapital first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $95.4M in Q4 2023. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Samsara BioCapital reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Samsara BioCapital sold 4,415,689 CARGO Therapeutics shares in Q3 2025, an estimated $18.2M.
Samsara BioCapital first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Samsara BioCapital's CARGO Therapeutics position peaked at $95.4M in Q4 2023.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Samsara BioCapital's 13F filing for Q3 2025, filed 14 Nov 2025.